Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dermatomyositis (DM)”

27 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 27 results

Post-approval studies (Phase 4)UnknownNCT01151644
What this trial is testing

Safety and Efficacy of Anti-Pandemic H1N1 Vaccination in Rheumatic Diseases

Who this might be right for
Rheumatoid ArthritisSpondyloarthritisSystemic Lupus Erythematosus (SLE)+9 more
University of Sao Paulo 5,000
Large-scale testing (Phase 3)Study completedNCT00651040
What this trial is testing

Combined Treatment of Methotrexate + Glucocorticoids Versus Glucocorticoids Alone in Patients With PM and DM

Who this might be right for
PolymyositisDermatomyositis
Institute of Rheumatology, Prague 31
Large-scale testing (Phase 3)Looking for participantsNCT05895786
What this trial is testing

Understand How the Study Medicine (PF-06823859) Works in People With Active Idiopathic Inflammatory Myopathies [Dermatomyositis (DM) and Polymyositis (PM)]

Who this might be right for
Myositis
Pfizer 318
Early research (Phase 1)Looking for participantsNCT06371417
What this trial is testing

Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)

Who this might be right for
Antiphospholipid Syndrome (APS)Bullous Pemphigoid (BP)Behçet's Syndrome (BS)+3 more
Chugai Pharmaceutical 144
Early research (Phase 1)Not Yet RecruitingNCT07729995
What this trial is testing

BAFF CAR-T Cells (LMY-922) for Treatment of Refractory Autoimmune Disease

Who this might be right for
Rheumatoid Arthritis (RA)Systemic Lupus Erthematosus (SLE)Dermatomyositis (DM)+1 more
Luminary Therapeutics 94
Testing effectiveness (Phase 2)Ended earlyNCT05650567
What this trial is testing

Study of M5049 in DM and PM Participants (NEPTUNIA)

Who this might be right for
DermatomyositisPolymyositis
EMD Serono Research & Development Institute, Inc. 20
Testing effectiveness (Phase 2)Study completedNCT00106184
What this trial is testing

Rituximab for the Treatment of Refractory Adult and Juvenile Dermatomyositis (DM) and Adult Polymyositis (PM)

Who this might be right for
MyositisDermatomyositisPolymyositis+1 more
University of Pittsburgh 200
Early research (Phase 1)Looking for participantsNCT07715136
What this trial is testing

BCMA-CD19 cCAR-T for the Treatment of Refractory Inflammatory Myopathy

Who this might be right for
Inflammatory Myopathy
iCell Gene Therapeutics 10
Large-scale testing (Phase 3)Study completedNCT00335985
What this trial is testing

Efficacy and Safety Study of GB-0998 for Treatment of Steroid-resistant Polymyositis and Dermatomyositis (PM/DM)

Who this might be right for
PolymyositisDermatomyositis
Japan Blood Products Organization 26
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06887738
What this trial is testing

Study of NM8074 in Patients with Dermatomyositis (DM)

Who this might be right for
Dermatomyositis
NovelMed Therapeutics 8
Testing effectiveness (Phase 2)Study completedNCT04628936
What this trial is testing

Open-label Extension to the Phase 2 Crossover Study (PRESIDIO) Evaluating KZR-616 in Patients With PM and DM.

Who this might be right for
PolymyositisDermatomyositis
Kezar Life Sciences, Inc. 18
Not applicableLooking for participantsNCT07377058
What this trial is testing

RCT of Tocilizumab for Anti-MDA5+DM

Who this might be right for
Dermatomyositis
Peking Union Medical College Hospital 110
Large-scale testing (Phase 3)Ended earlyNCT04044690
What this trial is testing

Evaluate the Efficacy, Safety, and Pharmacokinetics of IgPro20 in Adults With Dermatomyositis (DM)

Who this might be right for
Dermatomyositis
CSL Behring 134
Testing effectiveness (Phase 2)Ended earlyNCT02029274
What this trial is testing

Safety and Efficacy of BAF312 in Dermatomyositis

Who this might be right for
Active Dermatomyositis
Novartis Pharmaceuticals 17
Not applicableActive Not RecruitingNCT07531446
What this trial is testing

Construction of a Clinico-Imaging Collaborative Diagnostic Model for Dermatomyositis Combined With Interstitial Lung Disease Based on PET/CT Imaging Features and Clinical Parameters

Who this might be right for
Dermatomyositis (DM)ILDMachine Learning+1 more
Ruijin Hospital 200
Not applicableUnknownNCT05637931
What this trial is testing

Plexin D1 as a Potential Biomarker inPM/DM

Who this might be right for
PolymyositisDermatomyositis
Assiut University 66
Large-scale testing (Phase 3)Looking for participantsNCT07160205
What this trial is testing

Safety and Efficacy of ULSC on Disease Severity and Steroid Tapering in Participants With Dermatomyositis/ Polymyositis (DM/PM), Also Known as Idiopathic Inflammatory Myopathy (IIM)

Who this might be right for
Idiopathic Inflammatory Myositis (IIM)DERMATOMYOSITIS OR POLYMYOSITIS
Restem, LLC. 40
Testing effectiveness (Phase 2)Study completedNCT05669014
What this trial is testing

Proof of Concept Study to Evaluate the Efficacy and Safety of Daxdilimab in Participants With Dermatomyositis (DM) or Anti-synthetase Inflammatory Myositis (ASIM)

Who this might be right for
Idiopathic Inflammatory Myositis
Amgen 12
Large-scale testing (Phase 3)Ended earlyNCT04999020
What this trial is testing

Ravulizumab Versus Placebo in Adult Participants With Dermatomyositis

Who this might be right for
Dermatomyositis
Alexion Pharmaceuticals, Inc. 38
Large-scale testing (Phase 3)Study completedNCT02728752
What this trial is testing

Study Evaluating Efficacy and Safety of Octagam 10% in Patients With Dermatomyositis (Idiopathic Inflammatory Myopathy)

Who this might be right for
Dermatomyositis
Octapharma 95
Next Page